[go: up one dir, main page]

HK1079777A1 - Process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds, and application thereof - Google Patents

Process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds, and application thereof

Info

Publication number
HK1079777A1
HK1079777A1 HK05111843A HK05111843A HK1079777A1 HK 1079777 A1 HK1079777 A1 HK 1079777A1 HK 05111843 A HK05111843 A HK 05111843A HK 05111843 A HK05111843 A HK 05111843A HK 1079777 A1 HK1079777 A1 HK 1079777A1
Authority
HK
Hong Kong
Prior art keywords
benzazepin
tetrahydro
synthesis
compounds
application
Prior art date
Application number
HK05111843A
Other languages
English (en)
Inventor
Jean-Michel Lerestif
Jean-Pierre Lecouve
Jean-Claude Souvie
Daniel Brigot
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1079777A1 publication Critical patent/HK1079777A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK05111843A 2004-04-13 2005-12-22 Process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds, and application thereof HK1079777A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0403828A FR2868775B1 (fr) 2004-04-13 2004-04-13 Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Publications (1)

Publication Number Publication Date
HK1079777A1 true HK1079777A1 (en) 2006-04-13

Family

ID=34941961

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05111843A HK1079777A1 (en) 2004-04-13 2005-12-22 Process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds, and application thereof

Country Status (33)

Country Link
US (1) US7064200B2 (sl)
EP (1) EP1614687B1 (sl)
JP (2) JP4515933B2 (sl)
KR (1) KR100636499B1 (sl)
CN (1) CN100348585C (sl)
AR (1) AR047707A1 (sl)
AT (1) ATE448221T1 (sl)
AU (1) AU2005200884B2 (sl)
BR (1) BRPI0500590B8 (sl)
CA (1) CA2496712C (sl)
CY (1) CY1109740T1 (sl)
DE (1) DE602005017541D1 (sl)
DK (1) DK1614687T3 (sl)
EA (1) EA007743B1 (sl)
EG (1) EG25619A (sl)
ES (1) ES2336461T3 (sl)
FR (1) FR2868775B1 (sl)
GE (1) GEP20074136B (sl)
HK (1) HK1079777A1 (sl)
HR (1) HRP20100024T1 (sl)
MA (1) MA27598A1 (sl)
MX (1) MXPA05003696A (sl)
MY (1) MY140904A (sl)
NO (1) NO329861B1 (sl)
NZ (1) NZ538328A (sl)
PL (1) PL1614687T3 (sl)
PT (1) PT1614687E (sl)
RS (1) RS51232B (sl)
SG (1) SG116574A1 (sl)
SI (1) SI1614687T1 (sl)
UA (1) UA81773C2 (sl)
WO (1) WO2005111027A1 (sl)
ZA (1) ZA200501468B (sl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868775B1 (fr) * 2004-04-13 2008-04-11 Servier Lab Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
GT200500185A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
EP2471780B1 (en) 2007-05-30 2014-11-26 Ind-Swift Laboratories Limited Crystalline Ivabradine Oxalate Salts and Polymorphs Thereof
ES2402765T3 (es) 2008-12-22 2013-05-08 Krka, D.D., Novo Mesto Procedimiento de preparación de ivabradina
FR2940287B1 (fr) * 2008-12-24 2010-12-24 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
WO2011098582A2 (en) 2010-02-12 2011-08-18 Krka, D.D., Novo Mesto Novel forms of ivabradine hydrochloride
FR2956401B1 (fr) * 2010-02-17 2012-02-03 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2971507B1 (fr) * 2011-02-14 2013-01-18 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984320B1 (fr) * 2011-12-20 2013-11-29 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2993561B1 (fr) * 2012-07-17 2014-10-31 Servier Lab Procede de synthese enzymatique de la (7s)-1-(3,4-dimethoxy bicyclo[4.2.0]octa-1,3,5-triene 7-yl) n-methyl methanamine, et application a la synthese de l'ivabradine et de ses sels
FR3003859B1 (fr) * 2013-03-26 2015-03-13 Servier Lab "procede de synthese de derives de la 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one et application a la synthese de l'ivabradine"

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3418270A1 (de) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0204349A3 (de) * 1985-06-01 1990-01-03 Dr. Karl Thomae GmbH Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3519735A1 (de) * 1985-06-01 1986-12-04 Dr. Karl Thomae Gmbh, 7950 Biberach Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868775B1 (fr) * 2004-04-13 2008-04-11 Servier Lab Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Also Published As

Publication number Publication date
KR20060042117A (ko) 2006-05-12
NO20050888D0 (no) 2005-02-18
EA007743B1 (ru) 2006-12-29
JP2010047577A (ja) 2010-03-04
CN1683343A (zh) 2005-10-19
AU2005200884B2 (en) 2010-07-15
CY1109740T1 (el) 2014-09-10
US7064200B2 (en) 2006-06-20
EA200500240A1 (ru) 2005-10-27
MXPA05003696A (es) 2006-01-24
MA27598A1 (fr) 2005-11-01
DK1614687T3 (da) 2010-03-29
NO329861B1 (no) 2011-01-17
KR100636499B1 (ko) 2006-10-18
FR2868775A1 (fr) 2005-10-14
JP5277130B2 (ja) 2013-08-28
UA81773C2 (uk) 2008-02-11
EP1614687B1 (fr) 2009-11-11
ES2336461T3 (es) 2010-04-13
CA2496712C (fr) 2010-04-06
JP4515933B2 (ja) 2010-08-04
AU2005200884A1 (en) 2005-10-27
SI1614687T1 (sl) 2010-01-29
SG116574A1 (en) 2005-11-28
CA2496712A1 (fr) 2005-10-13
BRPI0500590B1 (pt) 2018-10-09
NO20050888L (no) 2005-10-14
PT1614687E (pt) 2009-12-02
JP2005298478A (ja) 2005-10-27
CN100348585C (zh) 2007-11-14
GEP20074136B (en) 2007-06-25
ATE448221T1 (de) 2009-11-15
BRPI0500590B8 (pt) 2021-05-25
WO2005111027A1 (fr) 2005-11-24
DE602005017541D1 (de) 2009-12-24
NZ538328A (en) 2005-10-28
EP1614687A1 (fr) 2006-01-11
ZA200501468B (en) 2005-11-30
BRPI0500590A (pt) 2005-11-16
RS51232B (sr) 2010-12-31
HRP20100024T1 (hr) 2010-02-28
EG25619A (en) 2012-03-26
US20050228178A1 (en) 2005-10-13
FR2868775B1 (fr) 2008-04-11
PL1614687T3 (pl) 2010-04-30
MY140904A (en) 2010-01-29
AR047707A1 (es) 2006-02-08

Similar Documents

Publication Publication Date Title
HK1081945A1 (en) Process for the synthesis of 4,5-dimethoxy-1-(methylaminomethyl)-benzocy clobutane, and the use thereof
HK1098737A1 (en) Process for the preparation of 1,1,1,3,3-pentafluoro-2-chloropropene and 1,1,1,3,3,3-hexafluoro-2-chloropropane
IL173456A0 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
HUE037069T2 (hu) Eljárás nagy tisztaságú 2,4'-metiléndifenildiizocianát elõállítására
IL180513A0 (en) Process for synthesis of 4-4'-diamino-diphenyl-sulfone
TWI346139B (en) Biochemical synthesis of 1,4-butanediamine
EP1884514A4 (en) PROCESS FOR THE OPTICAL SEPARATION OF 2-AMINO-6 PROPYLAMINO-4,5,6,7-TETRAHYDROBENZOTHIAZOL AND INTERMEDIATE PRODUCTS
HK1061846A1 (en) New process for the industrial synthesis of substituted thiophenecarboxylates, and application of such compounds
PT1664061T (pt) Processo para a síntese de compostos de morfinano e seus intermediários
HK1079777A1 (en) Process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds, and application thereof
PL1564203T3 (pl) Nowy sposób przemysłowej syntezy (7-metoksy-1-naftylo)acetonitrylu i jego zastosowanie w syntezie agomelatyny
IL175743A0 (en) Process for the preparation of thiazolopyrimidines
PL1807395T3 (pl) Sposób syntezy n-alkoksyamin
PL1564204T3 (pl) Nowy sposób wytwarzania (7-metoksy-3,4-dihydro-1-naftalenylo)acetonitrylu i jego zastosowanie do przemysłowej syntezy agomelatyny
HK1061845A1 (en) New process for the industrial synthesis of substituted thiophenecarboxylates, and application of such compounds
HK1079776A1 (en) The synthesis of 1,3-dihydro-2h-3-benzazepin-2-onecompounds, and the use thereof
HK1095145A1 (en) Process for the preparation of n-arylmorpholinones n-
IL182445A0 (en) Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4difluoromethoxy-8-methanesulfona mido-dibenzo[b,d]furan-1-caboxamide
GB2441840B (en) Process for the synthesis of arylfluorenes and analogues thereof
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
IL162770A0 (en) Process for the preparation methylsteroids of 7
HK1087111A1 (en) Process for the preparation of nicotinaldehydes
IL164788A0 (en) Process for the preparation of 3-isochromanone
EG24122A (en) Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines
ZA200601986B (en) Process for the synthesis of 3-(3-fluoro-4-hydroxyphenyl)-7-hydroxynaphthonitrile

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20250217